stockportfolio.pro
Amphastar Pharmaceuticals, Inc. EPS (Earnings per Share) 2012–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual earnings per share by fiscal year, computed from SEC filings. Compound growth +12.1%/yr over 13 years.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $2.03 | -33.7% |
| FY 2024 | $3.06 | +17.7% |
| FY 2023 | $2.60 | +49.4% |
| FY 2022 | $1.74 | +39.2% |
| FY 2021 | $1.25 | +4066.7% |
| FY 2020 | $0.03 | -96.9% |
| FY 2019 | $0.98 | +916.7% |
| FY 2018 | $-0.12 | -250.0% |
| FY 2017 | $0.08 | -61.9% |
| FY 2016 | $0.21 | +450.0% |
| FY 2015 | $-0.06 | +76.0% |
| FY 2014 | $-0.25 | -180.6% |
| FY 2013 | $0.31 | -32.6% |
| FY 2012 | $0.46 | — |
Source: Amphastar Pharmaceuticals, Inc. SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for Amphastar Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmphastar Pharmaceuticals, Inc. — frequently asked questions
What is Amphastar Pharmaceuticals, Inc.'s earnings per share?
Amphastar Pharmaceuticals, Inc. (AMPH) reported earnings per share of $2.03 for fiscal year 2025, per its SEC filings.
How has Amphastar Pharmaceuticals, Inc.'s earnings per share changed over time?
Between fiscal 2012 and 2025, AMPH's earnings per share grew at roughly 12.1% per year (compound annual rate), from $0.46 to $2.03.
Where does this data come from?
Figures are computed from Amphastar Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.